Bright Minds Biosciences (DRUG) Net Income (2020 - 2026)
Bright Minds Biosciences' (DRUG) quarterly Net Income came in at -$7.6 million in Q1 2026, down 483.85% YoY from $2.0 million in Q1 2025, and down 40.59% on a QoQ basis from -$5.4 million in Q4 2025.
Bright Minds Biosciences (DRUG) Net Income (2020 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 7 years of Net Income data on file, last reported at -$7.6 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 482.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 930.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -13.27 Mn |
| 10 | Bright Minds Biosciences | 733.05 Mn | 733.05 Mn | - | -7.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.63 Mn |
| Dec 31, 2025 | -5.42 Mn |
| Jun 30, 2025 | -7.97 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 35,513.28 |
| Jun 30, 2024 | -168,091.41 |
| Mar 31, 2024 | 2.93 Mn |
| Dec 31, 2023 | -1.24 Mn |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 1.72 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 3.85 Mn |
| Jun 30, 2021 | 2.87 Mn |
| Mar 31, 2021 | 1.25 Mn |
| Dec 31, 2020 | 511,669.18 |